These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26314506)

  • 1. MiR-335 is involved in major depression disorder and antidepressant treatment through targeting GRM4.
    Li J; Meng H; Cao W; Qiu T
    Neurosci Lett; 2015 Oct; 606():167-72. PubMed ID: 26314506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-155 is involved in major depression disorder and antidepressant treatment via targeting SIRT1.
    Wang X; Wang B; Zhao J; Liu C; Qu X; Li Y
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30482883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genetic variant in miRNA binding site of glutamate receptor 4, metabotropic (GRM4) is associated with increased risk of major depressive disorder.
    Dadkhah T; Rahimi-Aliabadi S; Jamshidi J; Ghaedi H; Taghavi S; Shokraeian P; Akhavan-Niaki H; Tafakhori A; Ohadi M; Darvish H
    J Affect Disord; 2017 Jan; 208():218-222. PubMed ID: 27792966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment.
    Lopez JP; Lim R; Cruceanu C; Crapper L; Fasano C; Labonte B; Maussion G; Yang JP; Yerko V; Vigneault E; El Mestikawy S; Mechawar N; Pavlidis P; Turecki G
    Nat Med; 2014 Jul; 20(7):764-8. PubMed ID: 24908571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant Expression of Intracellular let-7e, miR-146a, and miR-155 Correlates with Severity of Depression in Patients with Major Depressive Disorder and Is Ameliorated after Antidepressant Treatment.
    Hung YY; Wu MK; Tsai MC; Huang YL; Kang HY
    Cells; 2019 Jun; 8(7):. PubMed ID: 31252530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of microRNA-124 expression in peripheral blood mononuclear cells in pre- and post-treatment patients with major depressive disorder.
    He S; Liu X; Jiang K; Peng D; Hong W; Fang Y; Qian Y; Yu S; Li H
    J Psychiatr Res; 2016 Jul; 78():65-71. PubMed ID: 27078210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target.
    Goeldner C; Ballard TM; Knoflach F; Wichmann J; Gatti S; Umbricht D
    Neuropharmacology; 2013 Jan; 64():337-46. PubMed ID: 22992331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment.
    Muguruza C; Miranda-Azpiazu P; Díez-Alarcia R; Morentin B; González-Maeso J; Callado LF; Meana JJ
    Neuropharmacology; 2014 Nov; 86():311-8. PubMed ID: 25150943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in miRNA-132 and miR-124 levels in non-treated and citalopram-treated patients with depression.
    Fang Y; Qiu Q; Zhang S; Sun L; Li G; Xiao S; Li X
    J Affect Disord; 2018 Feb; 227():745-751. PubMed ID: 29689690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of miR-1202, miR-135a, and miR-16 in Major Depressive Disorder and Antidepressant Response.
    Fiori LM; Lopez JP; Richard-Devantoy S; Berlim M; Chachamovich E; Jollant F; Foster J; Rotzinger S; Kennedy SH; Turecki G
    Int J Neuropsychopharmacol; 2017 Aug; 20(8):619-623. PubMed ID: 28520926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chipping away at major depressive disorder.
    Rucker JJ; McGuffin P
    Genome Biol; 2014 Jul; 15(7):421. PubMed ID: 25315250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of circulating blood microRNA-374 and microRNA-10 levels in the pathogenesis and therapeutic mechanisms of major depressive disorder.
    Liu W; Zhang F; Zheng Y; He S; Zhang T; Guo Q; Xu H; Chen H; Liu C; Yu S; Jiang K; Li H; Li G; Wang X; Liu X
    Neurosci Lett; 2021 Oct; 763():136184. PubMed ID: 34418506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
    Chang HS; Won E; Lee HY; Ham BJ; Lee MS
    Behav Brain Res; 2015 Oct; 292():116-24. PubMed ID: 26055202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of child and adolescent depression.
    Moreno C; Roche AM; Greenhill LL
    Child Adolesc Psychiatr Clin N Am; 2006 Oct; 15(4):977-98, x. PubMed ID: 16952771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we increase the speed and efficacy of antidepressant treatments? Part II. Glutamatergic and RNA interference strategies.
    Artigas F; Celada P; Bortolozzi A
    Eur Neuropsychopharmacol; 2018 Apr; 28(4):457-482. PubMed ID: 29525411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant Histone Modification of TNFAIP3, TLR4, TNIP2, miR-146a, and miR-155 in Major Depressive Disorder.
    Tseng CC; Wang SC; Yang YC; Fu HC; Chou CK; Kang HY; Hung YY
    Mol Neurobiol; 2023 Aug; 60(8):4753-4760. PubMed ID: 37148522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamatergic NMDA Receptor as Therapeutic Target for Depression.
    Réus GZ; Abelaira HM; Tuon T; Titus SE; Ignácio ZM; Rodrigues AL; Quevedo J
    Adv Protein Chem Struct Biol; 2016; 103():169-202. PubMed ID: 26920690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNFAIP3, a negative regulator of the TLR signaling pathway, is a potential predictive biomarker of response to antidepressant treatment in major depressive disorder.
    Hung YY; Lin CC; Kang HY; Huang TL
    Brain Behav Immun; 2017 Jan; 59():265-272. PubMed ID: 27640899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging role of glutamate in the pathophysiology of major depressive disorder.
    Hashimoto K
    Brain Res Rev; 2009 Oct; 61(2):105-23. PubMed ID: 19481572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.